Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemofence for Hemostasis in Spinal/Orthopedic Surgery
NCT07824024Phase 3Completed
- Sponsor
- BMI OrganBank
- Start
- Dec 2020
- Primary completion
- Mar 2022
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in postoperative hemorrhage (2 arms), sponsored by BMI OrganBank. Primary endpoint: Percentage of Participants With Successful Hemostasis at the First Bleeding Site Within 10 Minutes. Started Dec 2020; status: completed.
02
Conditions
postoperative hemorrhage
Beyond the preview
Go deeper on NCT07824024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07824024.